Spastic Paraplegia Type 49
Overview
The first symptom of spastic paraplegia type 49 is typically weak muscle tone (hypotonia) that starts in infancy. The spasticity and paraplegia gradually worsen over time during childhood, leading to difficulty walking and frequent falls. Affected individuals may also have intellectual disability and distinctive physical features, including short stature, chubbiness, and smaller head size (microcephaly). There is currently no specific treatment to prevent or reverse progressive disability in patients with spastic paraplegia.
This condition is caused by pathogenic (disease-causing) variants in the TECPR2 gene. Additionally, spastic paraplegia type 49 exhibits autosomal recessive inheritance, meaning both parents must be carriers to have a 25% chance of having a child with the condition. The risk of being a carrier is based on a person’s ancestry or ethnic background. For example, individuals of Sephardic Jewish- Bukharian descent have a carrier frequency of 1 in 38. Carriers do not typically show any signs or symptoms of the condition.
Spastic paraplegia type 49 (SPG49) is a rare, complex inherited genetic disorder caused by mutations in the TECPR2 gene that leads to progressive muscle stiffness and lower-limb paralysis.
Symptoms
Infantile hypotonia: Weak muscle tone beginning in early infancy.
Progressive spasticity and paraplegia: Muscle stiffness and lower-limb weakness worsening during childhood, leading to difficulty walking, frequent falls, and a rigid or ataxic gait.
Distinctive physical features: Short stature, chubbiness/full cheeks, microcephaly (small head size), brachycephaly (short, broad head shape), short broad neck, and coarse facial features.
Reflex and sensory changes: Abnormal or absent reflexes and a reduced ability to feel pain or temperature sensations.
Feeding and swallowing issues: Difficulty feeding starting in infancy driven by autonomic neuron dysfunction.
Gastroesophageal reflux (GERD): Severe stomach acid backflow causing frequent vomiting.
Aspiration pneumonia: Recurrent, potentially life-threatening bacterial lung infections caused by fluid entering the lungs.
Breathing regulation problems: Central apnea (pauses in breathing during sleep and eventually while awake).
Autonomic instability: Irregular blood pressure, pulse rate, and body temperature regulation.
Severe episodic crises: Recurrent episodes of severe weakness, extreme hypotonia, and abnormal breathing that can require mechanical ventilation by early adulthood
Intellectual disability: Moderate to severe cognitive impairment and global developmental delay.
Seizures: Epilepsy develops in some affected individuals.Brain structural differences: Brain imaging may show cerebellar or cerebral atrophy and a thin corpus callosum.
Causes
TECPR2 Gene Mutation: Pathogenic variants (mutations) in the TECPR2 gene lead to an abnormal or absent TECPR2 protein.
Impaired Autophagy: The normal protein helps form autophagosomes—special compartments that isolate cellular waste for recycling (a process called autophagy). Loss of this function causes unneeded cellular waste to build up.
Vulnerability of Neurons: Long nerve extensions (axons and dendrites) struggle to transport this accumulated waste, leading to progressive cellular damage in motor, sensory, and autonomic neurons.
Autosomal Recessive: The condition is inherited when a person receives a mutated copy of the TECPR2 gene from both parents.
Carrier Risk: Parents of an affected individual are asymptomatic carriers. Carrier frequency is notably higher in specific populations, such as individuals of Sephardic Jewish-Bukharian descent.
Diagnosis
Clinical Examination: Doctors assess early-onset muscle weakness (hypotonia) in infancy, followed by progressive leg stiffness (spasticity) and walking difficulties during childhood.
Feature Assessment: Physicians look for associated signs of complex hereditary spastic paraplegia, including moderate-to-severe intellectual disability, microcephaly (small head size), short stature, and autonomic nervous system dysfunction (such as irregular breathing or feeding issues).
Genetic Testing: Definitive diagnosis relies on targeted gene sequencing or multi-gene panels to identify pathogenic (disease-causing) biallelic variants in the TECPR2 gene, confirming an autosomal recessive inheritance pattern.
Exclusion of Other Disorders: Neuroimaging (like an MRI) and other neurological tests may be used to rule out structural spinal cord issues or other forms of developmental delay and ataxia.
Treatment
Physical Therapy: Regular stretching, strengthening, and range-of-motion exercises help maintain muscle function and prevent joint contractures.
Medications for Spasticity: Oral muscle relaxants such as baclofen or tizanidine are used to ease severe muscle stiffness and spasms.
Mobility Support: Braces, walkers, or wheelchairs are provided based on individual needs to ensure safe movement.
Multidisciplinary Support: Care often involves specialists like neurologists, geneticists, and physical medicine experts to handle respiratory, developmental, and autonomic symptoms.
Type of Doctor Department : A neurologist
.jpg)
Comments
Post a Comment